PMID: 3277209Jan 1, 1988Paper

Metabolism of steroid-modifying anticancer agents

Pharmacology & Therapeutics
S P Robinson, V C Jordan


The application of steroid-modifying drugs as a strategy for the treatment of hormone-dependent cancers has gained increasing popularity during the past decade. However, it is important to point out and emphasize that very few of the agents were originally designed for their current application. Most were designed for other purposes, predominantly fertility control (e.g. LHRH agonists and the antiestrogens). Nevertheless, now it is possible to integrate their actions to design rational therapies. There are many reasons for the current interest in antisteroidal drugs. The initial euphoria over the potential ability of combination chemotherapy to cure breast and prostatic carcinoma has proved to be premature. Combination chemotherapy has many severe side-effects which limits patient acceptability, especially if the patient realizes that the likelihood of a cure is remote. In the main, antisteroidal therapies do not have many side-effects and those that do, e.g. aminoglutethimide, are the focus of increased efforts in drug design to produce increased drug specificity. Finally, there is a growing realization that hormone-dependent cancer control with a nontoxic, antisteroidal therapy may be the most acceptable approach currently av...Continue Reading


Jan 1, 1976·Hormone Research·E C Griffiths
Nov 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J GellerJ Albert
Jan 1, 1977·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·F Neumann
Apr 12, 1979·The New England Journal of Medicine·L A Klein
Aug 1, 1979·The Journal of Clinical Investigation·B M ShermanD Wycoff
Mar 1, 1975·Journal of Steroid Biochemistry·B G MobbsJ G Connolly
Mar 1, 1978·Journal of Toxicology and Environmental Health·V C JordanL Rowsby
Apr 1, 1979·Molecular and Cellular Endocrinology·E C Griffiths, J A Kelly
Nov 1, 1978·The Journal of Clinical Endocrinology and Metabolism·P KomanickyJ C Melby
Jan 1, 1979·Fertility and Sterility·L C Huppert
Jan 1, 1979·Hormone Research·E C Griffiths, C R Hopkinson
May 1, 1979·The Journal of Endocrinology·J Sandow, W König
Jun 1, 1979·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·L TharandtD Reinwein
Mar 1, 1977·Journal of Medicinal Chemistry·D RosiG O Potts
Mar 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonK Griffiths
Jun 1, 1979·Biochemical Society Transactions·R NeriA Watnick
May 28, 1979·Biochemical and Biophysical Research Communications·H RochefortJ L Borgna
Nov 1, 1979·The Journal of Urology·P C Sogani, W F Whitmore
May 1, 1979·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V C JordanB J Furr
Dec 14, 1979·Biochemical and Biophysical Research Communications·N BinartE E Baulieu
Nov 1, 1979·Journal of Clinical Pharmacology·F T MurrayR J Santen
Jul 15, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·M FrölichE C Brand
Jun 1, 1978·Endocrinology·W K Morishige, C A Uetake
Nov 1, 1977·The Journal of Endocrinology·V C JordanG Prestwich
Aug 1, 1978·The Journal of Endocrinology·S J GaskellR I Nicholson
Oct 1, 1978·The American Review of Respiratory Disease·H B Levine, J M Cobb
Jan 1, 1979·Biochemical Pharmacology·H K AdamJ V Kemp
Jan 1, 1976·European Journal of Obstetrics, Gynecology, and Reproductive Biology·J SandowG Jerzabek
Jun 1, 1976·The Journal of Investigative Dermatology·B KatchenG Millington
Dec 1, 1976·The Journal of Endocrinology·J S MajorP J Heald

❮ Previous
Next ❯


Aug 28, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Hiroyuki TakeiV Craig Jordan
Jan 1, 1994·European Journal of Drug Metabolism and Pharmacokinetics·Y TanakaS Ninomiya
May 13, 1994·Journal of Chromatography. B, Biomedical Applications·K M Fried, I W Wainer
Apr 12, 1996·Journal of Chromatography. B, Biomedical Applications·J MacCallumW R Miller
Jun 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·D PoirierF Labrie
Jan 1, 1991·The Journal of Steroid Biochemistry and Molecular Biology·R W KootP R Bär
Nov 1, 1995·Critical Reviews in Oncology/hematology·E Lønning, E A Lien
Feb 7, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·K Fried, I W Wainer
Nov 21, 1997·Journal of Chromatography. B, Biomedical Sciences and Applications·J MacCallumW R Miller
Mar 1, 1990·Baillière's Clinical Endocrinology and Metabolism·A HowellH Anderson
Aug 1, 1990·Breast Cancer Research and Treatment·S P RobinsonV C Jordan
Dec 1, 1988·European Journal of Cancer & Clinical Oncology·S P RobinsonV C Jordan
Jan 1, 1988·Critical Reviews in Clinical Laboratory Sciences·V C JordanW V Welshons
Jun 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacology & Therapeutics
B J Furr, V C Jordan
Journal of Pharmaceutical and Biomedical Analysis
D StevensonD De Vos
© 2021 Meta ULC. All rights reserved